These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16951131)

  • 21. Galectin-3 inhibition ameliorates hypoxia-induced pulmonary artery hypertension.
    Hao M; Li M; Li W
    Mol Med Rep; 2017 Jan; 15(1):160-168. PubMed ID: 27959409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement C3 deficiency attenuates chronic hypoxia-induced pulmonary hypertension in mice.
    Bauer EM; Zheng H; Comhair S; Erzurum S; Billiar TR; Bauer PM
    PLoS One; 2011; 6(12):e28578. PubMed ID: 22194859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension.
    Guignabert C; Izikki M; Tu LI; Li Z; Zadigue P; Barlier-Mur AM; Hanoun N; Rodman D; Hamon M; Adnot S; Eddahibi S
    Circ Res; 2006 May; 98(10):1323-30. PubMed ID: 16614302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung overexpression of angiostatin aggravates pulmonary hypertension in chronically hypoxic mice.
    Pascaud MA; Griscelli F; Raoul W; Marcos E; Opolon P; Raffestin B; Perricaudet M; Adnot S; Eddahibi S
    Am J Respir Cell Mol Biol; 2003 Oct; 29(4):449-57. PubMed ID: 12714372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxia-induced pulmonary hypertension.
    Morecroft I; Dempsie Y; Bader M; Walther DJ; Kotnik K; Loughlin L; Nilsen M; MacLean MR
    Hypertension; 2007 Jan; 49(1):232-6. PubMed ID: 17130306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smooth muscle protein 22alpha-mediated patchy deletion of Bmpr1a impairs cardiac contractility but protects against pulmonary vascular remodeling.
    El-Bizri N; Wang L; Merklinger SL; Guignabert C; Desai T; Urashima T; Sheikh AY; Knutsen RH; Mecham RP; Mishina Y; Rabinovitch M
    Circ Res; 2008 Feb; 102(3):380-8. PubMed ID: 18079409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of caveolin-1 by DJ-1 attenuates rat pulmonary arterial hypertension by inhibiting TGFβ/Smad signaling pathway.
    Gao W; Shao R; Zhang X; Liu D; Liu Y; Fa X
    Exp Cell Res; 2017 Dec; 361(1):192-198. PubMed ID: 29069575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial natriuretic peptide-dependent modulation of hypoxia-induced pulmonary vascular remodeling.
    Chen YF; Feng JA; Li P; Xing D; Ambalavanan N; Oparil S
    Life Sci; 2006 Aug; 79(14):1357-65. PubMed ID: 16714036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of hypoxic vasoconstriction by chronic hypoxia in rabbits: effects of nitric oxide.
    Weissmann N; Nollen M; Gerigk B; Ardeschir Ghofrani H; Schermuly RT; Gunther A; Quanz K; Fink L; Hänze J; Rose F; Seeger W; Grimminger F
    Am J Physiol Heart Circ Physiol; 2003 Mar; 284(3):H931-8. PubMed ID: 12433654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
    Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classical transient receptor potential channel 1 in hypoxia-induced pulmonary hypertension.
    Malczyk M; Veith C; Fuchs B; Hofmann K; Storch U; Schermuly RT; Witzenrath M; Ahlbrecht K; Fecher-Trost C; Flockerzi V; Ghofrani HA; Grimminger F; Seeger W; Gudermann T; Dietrich A; Weissmann N
    Am J Respir Crit Care Med; 2013 Dec; 188(12):1451-9. PubMed ID: 24251695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnesium attenuates endothelin-1-induced vasoreactivity and enhances vasodilatation in mouse pulmonary arteries: Modulation by chronic hypoxic pulmonary hypertension.
    Mu YP; Huang QH; Zhu JL; Zheng SY; Yan FR; Zhuang XL; Sham JSK; Lin MJ
    Exp Physiol; 2018 Apr; 103(4):604-616. PubMed ID: 29363240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative stress augments pulmonary hypertension in chronically hypoxic mice overexpressing the oxidized LDL receptor.
    Ogura S; Shimosawa T; Mu S; Sonobe T; Kawakami-Mori F; Wang H; Uetake Y; Yoshida K; Yatomi Y; Shirai M; Fujita T
    Am J Physiol Heart Circ Physiol; 2013 Jul; 305(2):H155-62. PubMed ID: 23686713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.
    Vermeersch P; Buys E; Pokreisz P; Marsboom G; Ichinose F; Sips P; Pellens M; Gillijns H; Swinnen M; Graveline A; Collen D; Dewerchin M; Brouckaert P; Bloch KD; Janssens S
    Circulation; 2007 Aug; 116(8):936-43. PubMed ID: 17679618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mice deficient in Mkp-1 develop more severe pulmonary hypertension and greater lung protein levels of arginase in response to chronic hypoxia.
    Jin Y; Calvert TJ; Chen B; Chicoine LG; Joshi M; Bauer JA; Liu Y; Nelin LD
    Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1518-28. PubMed ID: 20173047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyk2 aggravates hypoxia-induced pulmonary hypertension by activating HIF-1α.
    Fukai K; Nakamura A; Hoshino A; Nakanishi N; Okawa Y; Ariyoshi M; Kaimoto S; Uchihashi M; Ono K; Tateishi S; Ikeda K; Ogata T; Ueyama T; Matoba S
    Am J Physiol Heart Circ Physiol; 2015 Apr; 308(8):H951-9. PubMed ID: 25659487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transferrin Receptor 1 in Chronic Hypoxia-Induced Pulmonary Vascular Remodeling.
    Naito Y; Hosokawa M; Sawada H; Oboshi M; Hirotani S; Iwasaku T; Okuhara Y; Morisawa D; Eguchi A; Nishimura K; Soyama Y; Fujii K; Mano T; Ishihara M; Tsujino T; Masuyama T
    Am J Hypertens; 2016 Jun; 29(6):713-8. PubMed ID: 26419445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron is associated with the development of hypoxia-induced pulmonary vascular remodeling in mice.
    Naito Y; Hosokawa M; Sawada H; Oboshi M; Iwasaku T; Okuhara Y; Eguchi A; Nishimura K; Soyama Y; Hirotani S; Mano T; Ishihara M; Masuyama T
    Heart Vessels; 2016 Dec; 31(12):2074-2079. PubMed ID: 27311944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The nuclear factor erythroid 2-related factor 2 activator oltipraz attenuates chronic hypoxia-induced cardiopulmonary alterations in mice.
    Eba S; Hoshikawa Y; Moriguchi T; Mitsuishi Y; Satoh H; Ishida K; Watanabe T; Shimizu T; Shimokawa H; Okada Y; Yamamoto M; Kondo T
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):324-33. PubMed ID: 23590302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
    Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.